13D/13G Filings - Zylox-Tonbridge Medical Technology Co., Ltd.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-06-03
06:26 am
Purchase
2024-03-0513DAvinger, Inc.
AVGR
Zylox-Tonbridge Medical Technology Co., Ltd.1,981,655
49.900%
1,559,439increase
(+369.35%)
Filing
History
2024-03-14
9:37 pm
Purchase
2024-03-0513DAvinger, Inc.
AVGR
Zylox-Tonbridge Medical Technology Co., Ltd.422,216
19.900%
422,216increase
(New Position)
Filing
History